Celularity
CELU
32 hedge funds and large institutions have $3.85M invested in Celularity in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 3 closing their positions.
276% more call options, than puts
Call options by funds: $188K | Put options by funds: $50K
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
34% more capital invested
Capital invested by funds: $2.86M → $3.85M (+$983K)
19% more funds holding
Funds holding: 27 → 32 (+5)
3.84% more ownership
Funds ownership: 4.39% → 8.23% (+3.8%)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$107K |
| 2 |
State Street
Boston,
Massachusetts
|
+$92.6K |
| 3 |
BFO
Biltmore Family Office
Charlotte,
North Carolina
|
+$83.5K |
| 4 |
CAM
CenterStar Asset Management
Chicago,
Illinois
|
+$52.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$39.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$104K |
| 2 |
Renaissance Technologies
New York
|
-$29.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$11.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.73K |
CELU Hedge Fund Activity: Q4 2024 in Review
32 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q4 2024, worth a combined $3.85M — up 34% from $2.86M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new CELU positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 7 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $107K. The largest seller was Cresset Asset Management, exiting entirely with an estimated $104K sold.
- 32 institutional investors held Celularity (CELU) as of Q4 2024, up from 27 in Q3 2024.
- Funds reported $3.85M of Celularity stock for Q4 2024, up 34% quarter-over-quarter.
- 8 funds opened new Celularity positions in Q4 2024 and 3 closed out, a net change of +5 holders.
- The largest Celularity buyer in Q4 2024 was Two Sigma Investments, an estimated $107K added.
- The largest Celularity seller in Q4 2024 was Cresset Asset Management, an estimated $104K sold.
Based on aggregated 13F filings for Q4 2024.